119 related articles for article (PubMed ID: 2900827)
41. Optimization of restriction fragment length polymorphism and single strand conformation polymorphism analysis for the detection of point mutations of ras oncogenes in paraffin-embedded tissues.
Weise B; Ghebremedhin E; Zschunke F; Radzun HJ
Gen Diagn Pathol; 1996 Jun; 142(1):45-52. PubMed ID: 8793486
[TBL] [Abstract][Full Text] [Related]
42. Higher frequency of point mutations in the c-K-ras 2 gene in human colorectal adenomas with severe atypia than in carcinomas.
Ando M; Maruyama M; Oto M; Takemura K; Endo M; Yuasa Y
Jpn J Cancer Res; 1991 Mar; 82(3):245-9. PubMed ID: 1708754
[TBL] [Abstract][Full Text] [Related]
43. Comparison of restriction fragment length polymorphisms of proto-oncogenes in native Hawaiians and other ethnic groups in Hawaii.
Riley HD; Lau AF; Humphreys T
Hum Hered; 1992; 42(4):209-15. PubMed ID: 1355072
[TBL] [Abstract][Full Text] [Related]
44. Vitamin D receptor gene BsmI polymorphism correlates with erbB-2/HER-2 expression in human rectal cancer.
Speer G; Dworak O; Cseh K; Bori Z; Salamon D; Török I; Winkler G; Vargha P; Nagy Z; Takács I; Kucsera M; Lakatos P
Oncology; 2000 Apr; 58(3):242-7. PubMed ID: 10765127
[TBL] [Abstract][Full Text] [Related]
45. Association between restriction fragment length polymorphism of the L-myc gene and susceptibility to gastric cancer.
Shibuta K; Mori M; Haraguchi M; Yoshikawa K; Ueo H; Akiyoshi T
Br J Surg; 1998 May; 85(5):681-4. PubMed ID: 9635822
[TBL] [Abstract][Full Text] [Related]
46. Methylenetetrahydrofolate reductase polymorphism, alcohol intake, and risks of colon and rectal cancers in Korea.
Kim DH; Ahn YO; Lee BH; Tsuji E; Kiyohara C; Kono S
Cancer Lett; 2004 Dec; 216(2):199-205. PubMed ID: 15533596
[TBL] [Abstract][Full Text] [Related]
47. Polymorphisms in the transforming growth factor beta 1 pathway in relation to colorectal cancer progression.
Försti A; Li X; Wagner K; Tavelin B; Enquist K; Palmqvist R; Altieri A; Hallmans G; Hemminki K; Lenner P
Genes Chromosomes Cancer; 2010 Mar; 49(3):270-81. PubMed ID: 19998449
[TBL] [Abstract][Full Text] [Related]
48. Molecular staging of colorectal cancer: a step forward.
Liefers GJ; Tollenar RA; Cleton-Jansen AM
Gastroenterology; 1999 Mar; 116(3):769-70. PubMed ID: 10094604
[No Abstract] [Full Text] [Related]
49. Isolation and characterization of allelic losses and gains in colorectal tumors by arbitrarily primed polymerase chain reaction.
Peinado MA; Malkhosyan S; Velazquez A; Perucho M
Proc Natl Acad Sci U S A; 1992 Nov; 89(21):10065-9. PubMed ID: 1359533
[TBL] [Abstract][Full Text] [Related]
50. Landscape of genetic aberrations detected in human colorectal cancers.
Goto T; Marusawa H; Chiba T
Gastroenterology; 2013 Sep; 145(3):686-8. PubMed ID: 23891613
[No Abstract] [Full Text] [Related]
51. PPARgamma and colon and rectal cancer: associations with specific tumor mutations, aspirin, ibuprofen and insulin-related genes (United States).
Slattery ML; Curtin K; Wolff R; Ma KN; Sweeney C; Murtaugh M; Potter JD; Levin TR; Samowitz W
Cancer Causes Control; 2006 Apr; 17(3):239-49. PubMed ID: 16489531
[TBL] [Abstract][Full Text] [Related]
52. Restriction fragment length polymorphism and activation of c-Ha-ras gene in urothelial cancer.
Ishikawa J; Maeda S; Kamidono S; Sugiyama T
Anticancer Res; 1988; 8(5A):915-24. PubMed ID: 2902823
[TBL] [Abstract][Full Text] [Related]
53. Functional polymorphism in the MicroRNA-367 binding site as a prognostic factor for colonic cancer.
Chae YS; Kim JG; Kang BW; Lee SJ; Lee YJ; Park JS; Choi GS; Lee WK; Jeon HS
Anticancer Res; 2013 Feb; 33(2):513-9. PubMed ID: 23393343
[TBL] [Abstract][Full Text] [Related]
54. bcr rearrangement: potential false positive secondary to an Eco RI restriction fragment length polymorphism.
Fishleder AJ; Shadrach B; Tuttle C
Leukemia; 1989 Oct; 3(10):746-8. PubMed ID: 2570895
[TBL] [Abstract][Full Text] [Related]
55. A 0.5 kb insert polymorphism 3' to the c-myc gene.
Middleton PG; Guy K; DeAngelis CL; Steel CM
Nucleic Acids Res; 1988 Apr; 16(7):3123. PubMed ID: 2897116
[No Abstract] [Full Text] [Related]
56. Human in vitro cell lines verification by minisatellite DNA restriction fragment length polymorphism.
Mańczak M; Zielińska-Dawidziak M; Prussak M; Dubis J; Kość A; Duś D; Wojdat E; Kuśnierczyk P
Cancer Lett; 1998 Jun; 128(1):113-20. PubMed ID: 9652801
[TBL] [Abstract][Full Text] [Related]
57. [Loss of heterozygosity in human tumors].
Sasaki M; Sugio K; Sasazuki T
Rinsho Byori; 1989 Feb; Spec No 80():47-57. PubMed ID: 2576563
[No Abstract] [Full Text] [Related]
58. p380-8A 1.8 SaSs, a single copy clone 5' of c-myc at 8q24 which recognizes an SstI polymorphism.
Haluska FG; Huebner K; Croce CM
Nucleic Acids Res; 1987 Jan; 15(2):865. PubMed ID: 2881266
[No Abstract] [Full Text] [Related]
59. Loss of heterozygosity of p53 gene and p53 protein expression in human colorectal carcinomas.
Campo E; de la Calle-Martin O; Miquel R; Palacin A; Romero M; Fabregat V; Vives J; Cardesa A; Yague J
Cancer Res; 1991 Aug; 51(16):4436-42. PubMed ID: 1868464
[TBL] [Abstract][Full Text] [Related]
60. [Analysis of risk factors for bone metastasis after radical resection of colorectal cancer within 5 years].
Li A; Tan Z; Fu C; Wang H; Yuan J
Zhonghua Wei Chang Wai Ke Za Zhi; 2017 Jan; 20(1):58-61. PubMed ID: 28105621
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
